Weight-loss drug boom fuels protein powder sales — ride the Glanbia momentum
The massive boom in new weight-loss drugs like Ozempic is creating a huge wave of people buying protein powders and supplements. Glanbia, a major nutrition company, just saw its stock surge as everyday gym-goers use these drugs to accelerate fat loss while turning to protein to maintain muscle.
Idea
New weight-loss drugs are changing consumer habits, shifting demand toward high-protein diets and supplementation. Glanbia is directly capturing this trend as one of the largest makers of sports nutrition products globally. As more people adopt these medications, the demand for protein supplements is creating a sustainable, long-term growth tailwind for nutrition stocks. This provides a unique secondary play on the weight-loss drug craze outside of the pharmaceutical companies themselves.